Randomized Controlled Trial
Copyright ©The Author(s) 2016.
World J Transplant. Jun 24, 2016; 6(2): 429-436
Published online Jun 24, 2016. doi: 10.5500/wjt.v6.i2.429
Table 1 Demographic and baseline characteristics of the patients
FeaturesControl (n = 23)Intervention (n = 14)P
Male/female18 (78.3%)/5 (21.7%)11 (78.6%)/3 (21.4%)1.00
Age (yr)55.4 ± 9.955.8 ± 5.40.97
BMI (kg/m2)27.3 ± 4.528.6 ± 5.40.58
Diagnosis
HCV5 (21.7%)4 (28.6%)
HCC + HCV4 (17.4%)
Alcohol3 (13%)3 (21.4%)
HCC3 (13%)
Alcohol + HCV3 (13%)2 (14.2%)
Alcohol + HCC1 (4.3%)
Alcohol + HCV + HCC1 (4.3%)2 (14.2%)
Autoimmune hepatitis1 (4.3%)
Polycystic liver disease1 (4.3%)
Cryptogenic cirrhosis1 (7.1%)
Sclerosing cholangitis1 (7.1%)
HBV + HCV1 (7.1%)